Dogs and cats with acute-on-chronic kidney disease have worse outcomes than those with acute kidney injury following renal replacement therapy.

Authors

Woonchan Ahn, Keon Kim, Jinhae Kim, Yujin Lee, Taeho Lee, Jiwoong Her

Published in

Frontiers in veterinary science. Volume 13. Pages 1857111. Epub Jul 30, 2026.

Abstract

To compare survival to discharge and long-term outcomes in dogs and cats with acute-on-chronic kidney disease (ACKD) compared to acute kidney injury (AKI) treated with renal replacement therapy (RRT) and to identify factors associated with outcome.
Retrospective observational design.
Single referral hospital.
136 client-owned animals (67 dogs and 69 cats) treated with RRT between 2017 and 2024.
This retrospective observational cohort study reviewed medical records from a referral hospital. Animals were classified as having ACKD (n = 66) or AKI (n = 70). Short-term survival was evaluated as survival to discharge, restricted mean survival time (RMST) and logistic regression models. Long-term survival was assessed using Kaplan-Meier analysis, RMST and Cox proportional hazards models. Animals with ACKD were older than those with AKI (10.4 ± 3.9 years vs. 6.3 ± 3.3 years; p < 0.0001) and had higher serum creatinine concentrations at discharge (3.38 ± 1.16 mg/dL vs. 2.81 ± 2.92 mg/dL; adjusted p = 0.0073). Survival to discharge was 53% (35/66) for ACKD and 70% (49/70) for AKI. Short-term survival did not differ significantly between groups (log-rank p = 0.089). Among animals survived to discharge, RMST was shorter for ACKD. Median survival time for the ACKD group was 57 days overall and 33 days for dogs.
Although statistically significant differences were not identified, dogs and cats with ACKD had lower survival to discharge and numerically shorter long-term survival than animals with AKI. Nevertheless, 53% of RRT-treated animals with ACKD survived to discharge, demonstrating that short-term survival is achievable in selected ACKD patients.

PMID:
42603023
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.